These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. Laupland KB; Ross T; Gregson DB J Infect Dis; 2008 Aug; 198(3):336-43. PubMed ID: 18522502 [TBL] [Abstract][Full Text] [Related]
4. [Impact of an infectious diseases consultation service on the quality of care and the survival of patients with infectious diseases]. Rieg S; Küpper MF Z Evid Fortbild Qual Gesundhwes; 2015; 109(7):500-10. PubMed ID: 26593765 [TBL] [Abstract][Full Text] [Related]
5. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia. Melzer M; Eykyn SJ; Gransden WR; Chinn S Clin Infect Dis; 2003 Dec; 37(11):1453-60. PubMed ID: 14614667 [TBL] [Abstract][Full Text] [Related]
6. Impact of a pharmacist-driven care package on Staphylococcus aureus bacteremia management in a large community healthcare network: A propensity score-matched, quasi-experimental study. Smith JR; Frens JJ; Snider CB; Claeys KC Diagn Microbiol Infect Dis; 2018 Jan; 90(1):50-54. PubMed ID: 29153470 [TBL] [Abstract][Full Text] [Related]
7. Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy. Gasch O; Camoez M; Dominguez MA; Padilla B; Pintado V; Almirante B; Molina J; Lopez-Medrano F; Ruiz E; Martinez JA; Bereciartua E; Rodriguez-Lopez F; Fernandez-Mazarrasa C; Goenaga MA; Benito N; Rodriguez-Baño J; Espejo E; Pujol M; Clin Microbiol Infect; 2013 Nov; 19(11):1049-57. PubMed ID: 23331461 [TBL] [Abstract][Full Text] [Related]
8. Staphylococcus aureus bacteremia, risk factors, complications, and management. Keynan Y; Rubinstein E Crit Care Clin; 2013 Jul; 29(3):547-62. PubMed ID: 23830653 [TBL] [Abstract][Full Text] [Related]
10. Epidemiology, clinical characteristics and treatment outcomes of healthcare- associated methicillin-resistant Staphylococcus aureus BLOODSTREAM infections at Chiang Mai University Hospital: a retrospective study. Chaiwarith R; Pacharasupal P; Sirisanthana T Southeast Asian J Trop Med Public Health; 2014 Jul; 45(4):897-905. PubMed ID: 25427359 [TBL] [Abstract][Full Text] [Related]
11. Empirical antimicrobial therapy for bloodstream infection due to methicillin-resistant Staphylococcus aureus: no better than a coin toss. Herzke CA; Chen LF; Anderson DJ; Choi Y; Sexton DJ; Kaye KS Infect Control Hosp Epidemiol; 2009 Nov; 30(11):1057-61. PubMed ID: 19803766 [TBL] [Abstract][Full Text] [Related]
12. Mandatory infectious diseases consultation for MRSA bacteremia is associated with reduced mortality. Tissot F; Calandra T; Prod'hom G; Taffe P; Zanetti G; Greub G; Senn L J Infect; 2014 Sep; 69(3):226-34. PubMed ID: 24844825 [TBL] [Abstract][Full Text] [Related]
14. Telavancin for refractory methicillin-resistant Staphylococcus aureus bacteremia and infective endocarditis. Ruggero MA; Peaper DR; Topal JE Infect Dis (Lond); 2015 Jun; 47(6):379-84. PubMed ID: 25746601 [TBL] [Abstract][Full Text] [Related]
15. Early response assessment to guide management of methicillin-resistant Staphylococcus aureus bloodstream infections with vancomycin therapy. Joo J; Yamaki J; Lou M; Hshieh S; Chu T; Shriner KA; Wong-Beringer A Clin Ther; 2013 Jul; 35(7):995-1004. PubMed ID: 23829982 [TBL] [Abstract][Full Text] [Related]
16. Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci. Kim SH; Park WB; Lee KD; Kang CI; Kim HB; Oh MD; Kim EC; Choe KW Clin Infect Dis; 2003 Sep; 37(6):794-9. PubMed ID: 12955640 [TBL] [Abstract][Full Text] [Related]